[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335416-105":59,"doc-detail-335416-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","searching-for-new-biomarkers-of-neuroendocrine-tumors-a-comparative-analysis-of-chromogranin-a-and-inflammatory-cytokines","Searching for New Biomarkers of Neuroendocrine Tumors - A Comparative Analysis of Chromogranin A and Inflammatory Cytokines","","Neuroendocrine neoplasms (NENs) pose diagnostic challenges because of their heterogeneous biology and non-specific clinical presentations. This study evaluated serum chromogranin A (CgA) and a panel of 48 inflammatory cytokines in 84 NEN patients and 40 healthy controls using ELISA and multiplex ELISA. Cytokine profiling revealed significant dysregulation, with elevated pro-inflammatory cytokines (e.g., IL-6, IL-8, TNF-α) and reduced angiogenic-related factors (e.g., PDGF-BB, TNF-β). GRO-α and TNF-β showed strong diagnostic potential, and CgA correlated with multiple inflammatory cytokines, supporting a multi-marker strategy over CgA alone. Larger cohorts are needed for validation and clinical translation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/searching-for-new-biomarkers-of-neuroendocrine-tumors-a-comparative-analysis-of-chromogranin-a-and-inflammatory-cytokines/335416/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/searching-for-new-biomarkers-of-neuroendocrine-tumors-a-comparative-analysis-of-chromogranin-a-and-inflammatory-cytokines/335416.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What biomarkers were compared in the study?","Question",{"text":112,"@type":113},"The study compared serum chromogranin A (CgA) levels and a panel of 48 inflammatory cytokines to identify potential diagnostic markers for neuroendocrine neoplasms.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the biomarkers measured?",{"text":117,"@type":113},"CgA and cytokines were measured in patients and controls using enzyme-linked immunosorbent assay (ELISA) and multiplex ELISA.",{"name":119,"@type":110,"acceptedAnswer":120},"Which cytokines showed the strongest diagnostic performance?",{"text":121,"@type":113},"GRO-α and TNF-β demonstrated strong diagnostic potential, with ROC curve analyses indicating high sensitivity and specificity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335416,1790617368,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Article  \nSearching for New Biomarkers of Neuroendocrine Tumors: A Comparative Analysis of Chromogranin A and Inflammatory Cytokines in Patients with Neuroendocrine Tumors  \nMarlena Budek 1, Jarosław Nuszkiewicz 1, Jolanta Czuczejko 2,3, Marta Maruszak-Parda 3,  \nJoanna Wróblewska 1, Jakub Wojtasik 4, Iga Hoły ´nska-Iwan 5, Marta Pawłowska 1, Alina Wo´zniak 1 and Karolina Szewczyk-Golec 1, *  \nCitation: Budek, M.; Nuszkiewicz, J.; Czuczejko, J.; Maruszak-Parda, M.; Wróblewska, J.; Wojtasik, J.;  \nHoły ´nska-Iwan, I.; Pawłowska, M.; Wo´zniak, A.; Szewczyk-Golec, K. Searching for New Biomarkers of Neuroendocrine Tumors: A Comparative Analysis of Chromogranin A and Inflammatory Cytokines in Patients with Neuroendocrine Tumors. Curr. Oncol. 2024, 31, 6110–6132. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/curroncol31100456](10.3390/curroncol31100456)  \nReceived: 2 September 2024  \nRevised: 7 October 2024  \nAccepted: 10 October 2024  \nPublished: 12 October 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru ´n, 87-100 Toru ´n, Poland; [marlenamarkiewicz@o2.pl](marlenamarkiewicz@o2.pl) (M.B.); [jnuszkiewicz@cm.umk.pl](jnuszkiewicz@cm.umk.pl) (J.N.); [joanna.wroblewska@cm.umk.pl](joanna.wroblewska@cm.umk.pl) (J.W.); [marta.pawlowska@cm.umk.pl](marta.pawlowska@cm.umk.pl) (M.P.); [al1103@cm.umk.pl](al1103@cm.umk.pl) (A.W.)  \n2 Department of Psychiatry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru ´n, 87-100 Toru ´n, Poland; [joczu@cm.umk.pl](joczu@cm.umk.pl)  \n3 Department of Nuclear Medicine, Oncology Centre Prof. Franciszek Łukaszczyk Memorial Hospital, 85-796 Bydgoszcz, Poland; [maruszakm@co.bydgoszcz.pl](maruszakm@co.bydgoszcz.pl)  \n4 Centre for Statistical Analysis, Nicolaus Copernicus University in Toru ´n, 87-100 Toru ´n, Poland; [jwojtasik@umk.pl](jwojtasik@umk.pl)  \n5 Department of Pathobiochemistry and Clinical Chemistry, Faculty of Pharmacy, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 87-100 Toru ´n, Poland; [igaholynska@cm.umk.pl](igaholynska@cm.umk.pl)  \n* Correspondence: [karosz@cm.umk.pl](karosz@cm.umk.pl); Tel.: +48-52-585-37-55  \nAbstract: Neuroendocrine neoplasms (NENs) present a diagnostic challenge due to their heterogeneous nature and non-specific clinical manifestations. This study aimed to explore novel biomarkers for NENs. Serum chromogranin A (CgA) levels and a panel of 48 inflammatory cytokines were analyzed in a cohort of 84 NEN patients and 40 healthy controls using enzyme-linked immunosorbent assay (ELISA) and multiplex ELISA. Significant alterations in cytokine levels were observed in the NEN patients compared to the controls, including elevated levels of pro-inflammatory cytokines, such as interleukin (IL)-6, IL-8, and tumor necrosis factor alpha (TNF-α), and reduced levels of angiogenic factors like platelet-derived growth factor-BB (PDGF-BB) and tumor necrosis factor beta (TNF-β) . Notably, cytokines such as growth-regulated alpha protein (GRO-α) and TNF-β demonstrated strong potential as diagnostic markers, with receiver operating characteristic (ROC) curve analyses showing high sensitivity and specificity. Additionally, a positive correlation was found between CgA levels and several inflammatory cytokines, suggesting their synergistic role in tumor progression. These findings highlight the limited reliability of CgA alone as a diagnostic marker and underscore the importance of a multi-marker approach in diagnos","cbCaiia2svsf5iVJ","https://ap.wps.com/l/cbCaiia2svsf5iVJ","pdf",3536760,23,"English","# Abstract\n# Introduction\n## Diagnostic challenges in NENs\n## Imaging and biomarker development\n## Hereditary MEN and early diagnosis","[{\"question\":\"What biomarkers were compared in the study?\",\"answer\":\"The study compared serum chromogranin A (CgA) levels and a panel of 48 inflammatory cytokines to identify potential diagnostic markers for neuroendocrine neoplasms.\"},{\"question\":\"How were the biomarkers measured?\",\"answer\":\"CgA and cytokines were measured in patients and controls using enzyme-linked immunosorbent assay (ELISA) and multiplex ELISA.\"},{\"question\":\"Which cytokines showed the strongest diagnostic performance?\",\"answer\":\"GRO-α and TNF-β demonstrated strong diagnostic potential, with ROC curve analyses indicating high sensitivity and specificity.\"}]","Searching for New Biomarkers of Neuroendocrine Tumors - A Comparative Analysis of Chromogranin A and Inflammatory Cytokines | PDF",1790010908,58]